MRI  Vol.2 No.1 , February 2013
The effect of alpha asarone, olive oil, and dexamethasone on collagen-induced arthritis (CIA) in the mouse
Aim of the Study: The primary aim of the study was to test the effect of 2,4,5-trimethoxy-1-propenylbenzene (alpha asarone), a hypocholes terolaemic drug, on the progression of collagen induced arthritis (CIA) in mice. Olive oil,the vehicle of alpha-asarone, and dexamethasonewere used as control treatments. Set-Up: Four groups of DBA/1 mice were immunised with chicken type II collagen (CII) via the intradermal route and either left untreated or were treated with alpha asarone, olive oil, or dexamethasone. A non-immunised group was an additional control. Follow-Up: The thicknesses of the rear and front footpads were continuously monitored, and the levels of anti-collagen antibodies were measured at the end of the experiment. The animals were then sacrificed, and their rear and front limbs were removed and processed forhistological examination. Results: Alpha asarone had no anti-inflammatory effect on CIA, and in one third of the animals, it showed a proinflammatory effect that was characterised by a marked accumulation of neutrophils. Olive oil did not show any obvious antiinflammatory effect on CIA, but it lowered the level of CII antibodies by 50%, suggesting a potential long-term antiinflammatory effect. As expected, dexamethasone had a clear anti-inflammatory effect on CIA. Con- clusion: Alpha asarone did not show any antiinflammatory effect on CIA in the mice under the above conditions; however, the accumulation of neutrophils in the CIA lesions of mice treated with alpha asarone and the effect of olive oil in downregulating the levels of anti-CII antibodies in CIA are two findings that warrant further investigation.

Cite this paper
Aquino-Vega, M., Rodríguez-Páez, L., Arce-Paredes, P., Hernández-Chávez, V., Becerril-Villanueva,E. and Rojas-Espinosa, O. (2013) The effect of alpha asarone, olive oil, and dexamethasone on collagen-induced arthritis (CIA) in the mouse. Modern Research in Inflammation, 2, 9-20. doi: 10.4236/mri.2013.21002.
[1]   Martínez, M. (1992) Las plantas medicinales de México. 6th Edición, Editorial Botas, México.

[2]   Sánchez-Reséndiz, J., Lerdo de Tejada, A., González-Vite, J. et al. (1980) Acción hipocolesterolemiante de Guat- teria gaumeri. Traditional Medicine, 3, 20-22.

[3]   Enríquez, R.G., Chávez, M.A. and Jáuregui, F. (1980) Propenylbenzenes from Guatteria gaumeri. Phytochem- istry, 19, 2024-2025. doi:10.1016/0031-9422(80)83029-9

[4]   Mandoki, J.J., Krumm-Heller, C., Vega-Noverola, J., et al. (1980) Isolation of alpha-asarone from the bark of Guat- teria gaumeri (Elemuy) and the study of its hypocholes- terolemic effect. IV National Congress of Pharmacology, Merida, 18-20 March 1980.

[5]   Seshadri, T.R. and Thiruvengadam, T.R. (1950) A new synthesis of asarone. Proceedings of the Indian Academy of Science, 32A, 110-113.

[6]   Díaz, F., Contreras, I., Flores, R., et al. (1990) An effi- cient synthesis of alpha asarone. Organic Preparations and Procedures International, 23, 133-138. doi:10.1080/00304949109458299

[7]   Poplawski, J., Lozowicka, B., Dubis, A.T., et al. (2000) Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo). Journal of Medicinal Chemistry, 43, 3671-3676. doi:10.1021/jm000905n

[8]   Gómez, C., Chamorro, G., Chávez, M.A., et al. (1987) Effect de l’alpha-asarone sur hypercholesterolemic et la cholelitiasis experimentales. Planta Medica Phytotherapy, 21, 279-284.

[9]   Gardu?o, L., Salazar, M., Salazar, S., et al. (1997) Hypo- lipidaemic activity of alpha-asarone in mice. Journal of Ethnopharmacology, 55, 161-163. doi:10.1016/S0378-8741(96)01492-4

[10]   Rodríguez-Páez, L., Juárez-Sánchez, M., Antúnez-Solís, J., et al. (2003) α-asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats. Phytomedicine, 10, 397-402. doi:10.1078/0944-7113-00274

[11]   Estruch, R. (2010) Anti-inflammatory effects of the Me- diterranean diet: The experience of the PREDIMED study. Proceedings of the Nutrition Society, 69, 333-340. doi:10.1017/S0029665110001539

[12]   Waterman, E. and Lockwood, B. (2007) Active compo- nents and clinical applications of olive oil. Alternative Medicine Review, 12, 331-342.

[13]   Papageorgiou, N., Tousoulis, D., Psaltopoulou, T., et al. (2011) Divergent anti-inflammatory effects of different oil acute consumption on healthy individuals. European Journal of Clinical Nutrition, 65, 514-519.

[14]   Impellizzeri, D., Esposito, E., Mazzon, E., et al. (2011) Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. Journal of Pharmacology and Experi- mental Therapeutics, 339, 859-869.

[15]   Jaffré, B., Watrin, A., Loeuille, D., et al. (2003) Effects of antiinflamatory drugs on arthritic cartilage: A high-fre- quency quantitative ultrasound study in rats. Arthritis & Rheumatism, 48, 1594-1601. doi:10.1002/art.11023

[16]   Yang, Y.H., Morand, E.F., Getting, S.J., et al. (2004) Modulation of inflammation and response dexamethasone by annexin 1 in antigen-induced arthritis. Arthritis & Rheumatism, 50, 976-984. doi:10.1002/art.20201

[17]   Islander, U., Jochems, C., Stubelius, A., et al. (2011) Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis. Arthritis Research & Therapy, 13, R96. doi:10.1186/ar3371

[18]   Anderson, R., Franch, A., Castell, M., et al. (2010) Lipo- somal encapsulation enhances and prolongs the anti-in- flammatory effects of water-soluble dexamethasone phos- phate in experimental adjuvant arthritis. Arthritis Re- search & Therapy, 12, R147. doi:10.1186/ar3089

[19]   Kroot, E.J., Huisman, A.M., Van Zeben, J., et al. (2006) Oral pulsed dexamethasone therapy in early rheumatoid arthritis: A pilot study. Annals of the New York Academy of Sciences, 1069, 300-306. doi:10.1196/annals.1351.028

[20]   Bos, W.H., Dijkmans, B.A., Boers, M., et al. (2010) Ef- fect of dexamethasone on autoantibody levels and arthri- tis development in patients with arthralgia: A radomised trial. Annals of the Rheumatic Diseases, 69, 571-574. doi:10.1136/ard.2008.105767

[21]   Brand, D.D. (2005) Rodent models of rheumatoid arth- ritis. Comparative Medicine, 55, 114-122.

[22]   Brand, D.D., Latham, K.A. and Rosloniec, E.F. (2007) Collagen-induced arthritis. Nature Protocols, 2, 1269- 1275. doi:10.1038/nprot.2007.173

[23]   Andersson, A.K., Li, C. and Brennan, F.M. (2008) Recent developments in the immunobiology of rheumatoid ar- thritis. Arthritis Research & Therapy, 10, 24. doi:10.1186/ar2370

[24]   Asquith, D.L., Miller, A.M., McIcnnes, J.B. et al. (2009) Animal models of rheumatoid arthritis. European Journal of Immunology, 39, 1991-2058. doi:10.1002/eji.200939578

[25]   Nguyen, T.G., Little, C.B., Yenson, V.M., et al. (2010) Anti-IgD antibody attenuates collagen-induced arthritis by selectively depleting mature B-cells and promoting immune tolerance. Journal of Autoimmunity, 35, 86-97. doi:10.1016/j.jaut.2010.03.003

[26]   Shaw, J., Chen, B., Wooley, P., et al. (2011) Anti-inflam- matory and anti-arthritic effects of a novel leflunomide analogue, UTL-5b (GBL-5b). American Journal of Bio- medical Sciences, 3, 31-39. doi:10.5099/aj110100031

[27]   Inglis, J.J., ?imelyte, E., McCann, F.E., et al. (2008) Pro- tocol for the induction of arthritis in C57BL/6 mice. Na- ture Protocols, 4, 612-618. doi:10.1038/nprot.2008.19

[28]   Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685. doi:10.1038/227680a0

[29]   Seraffini-Fracassini, A. and Smith, J.W. (1974) Collagen. The structure and biochemistry of cartilage. Churchill Livingstone, Edinburgh.

[30]   Sheehan, D.C. and Hrapchak, B.B. (1980) Theory and practice of histotechnology. 2nd Edition, The CV Mosby Company, St Louis.

[31]   Vinaccia, S., Tobón, S., Moreno, S.-P., et al. (2005) Evaluación de la calidad de vida en pacientes con diagnóstico de artritis reumatoide. International Journal of Psychology and Psychological Therapy, 5, 45-59.

[32]   Aletaha, D., Neogi, T., Silman, A.J., et al. (2010) Rheu- matoid arthritis classification criteria: An American Col- lege of Rheumatology/European League against Rheuma- tism collaborative initiative. Arthritis & Rheumatism, 62, 2569-2581. doi:10.1002/art.27584

[33]   Hewlett, S., Sanderson, T., May, J., et al. (2011) “I’m hurting, I want to kill myself”: Rheumatoid arthritis flare is more than a high joint count—An international patient perspective on flare where medical help is sought. Rheu- matology, Oxford.

[34]   Díaz-Jouanen, E., Abud-Mendoza, C., Garza-Elizondo, M.A., et al. Recommendations for the medical treatment of rheumatoid arthritis. Revista de Investigación Clínica, 57, 735-755.

[35]   Pratt, A.G., Issacs, J. and Mattey, D.L. (2009) Current concepts in the pathogenesis of early rheumatoid arthritis. Best Practice & Research Clinical Rheumatology, 23, 37- 38. doi:10.1016/j.berh.2008.08.002

[36]   Low, J.M. and Moore, T.L. (2005) A role for the com- plement system in rheumatoid arthritis. Current Pharm- aceutical Design, 11, 655-670. doi:10.2174/1381612053381936

[37]   Okroj, M., Heineg?rd, D., Holmdahl, R., et al. (2007) Rheumatoid arthritis and the complement system. Annals of Medicine, 39, 517-530. doi:10.1080/07853890701477546

[38]   Firestein, G.S. (2005) Pathogenesis of rheumatoid arthri- tis: How early is early? Arthritis Research & Therapy, 7, 157-159. doi:10.1186/ar1780

[39]   Rindfleisch, J.A. and Muller, D. (2005) Diagnosis and management of rheumatoid arthritis. American Family Physician, 72, 1037-1047.

[40]   Otero, M. and Goldring, M.B. (2007) Cells of the syno- vium in rheumatoid arthritis. Chondrocytes. Arthritis Research & Therapy, 9, 220. doi:10.1186/ar2292

[41]   Rosloniec, E.F., Brand, D.D., Myers, L.K., et al. (1997) An HLA-DR1 transgene confers susceptibility to colla- gen-induced arthritis elicited with human type II collagen. Journal of Experimental Medicine, 185, 1113-1122. doi:10.1084/jem.185.6.1113

[42]   Rosloniec, E.F., Brand, D.D., Myers, L.K., et al. (1998) Induction of autoimmune arthritis in HLA-DR4 (DRB1* 0401) transgenic mice by immunization with human and bovine type II collagen. Journal of Immunology, 160, 2573-2578.

[43]   Kamradt, T. and Frey, O. (2010) Arthritis: Where are the T cells? Arthritis Research & Therapy, 12, 122. doi:10.1186/ar3008

[44]   Barsante, M.M., Roffê, E., Yokoro, C.M., et al. (2005) Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. European Jour- nal of Pharmacology, 516, 282-289. doi:10.1016/j.ejphar.2005.05.005

[45]   Yamagata, T., Kinoshita, K., Nozaki, Y., et al. (2010) Effects of pravastatin in murine collagen-induced arthritis. British Journal of Clinical Pharmacologyi, 69, 85-94.

[46]   Lubberts, E., Koenders, M.I. and Van den Berg, W.B. (2005) The role of T cell interleukin-17 in conducting de- structive arthritis. Lessons from animal models. Arthritis Research & Therapy, 7, 29-37. doi:10.1186/ar1550

[47]   Raza, K., Falciani, F., Curnow, S.J., et al. (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stro- mal cell origin. Arthritis Research & Therapy, 7, R784- R795. doi:10.1186/ar1733

[48]   Lundy, S.K., Sarkar, S., Tesmer, L.A., et al. (2007) Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Research & Therapy, 9, 202. doi:10.1186/ar2107

[49]   Earp, J.C., Dubois, D.C., Molano, D.S., et al. (2008). Modeling corticosteroid effects in a rat model of rheu- matoid arthritis: Mechanistic pharmacodynamic model for dexamethasone effects in Lewis rats with collagen- induced arthritis. Journal of Pharmacology and Experi- mental Therapeuticsi, 326, 546-554. doi:10.1124/jpet.108.137372

[50]   Liu, X.M., Quan, L.D., Tian, J., et al. (2008) Synthesis and evaluation of a well-defined HPMA copolymer- dexamethasone conjugate for effective treatment of rheu- matoid arthritis. Pharmaceutical Research, 25, 2910- 2919. doi:10.1007/s11095-008-9683-3

[51]   De, A., Blotta, H.M., Mamoni, R.L., et al. (2002) Effects of dexamethasone on lymphocyte proliferation and cyto- kine production in rheumatoid arthritis. Journal of Rheumatology, 29, 46-51.

[52]   Santini, G., Patrignani, P., Sciulli, M.G., et al. (2001) The human pharmacology of monocyte cyclooxygenase 2 in- hibition by cortisol and synthetic glucocorticoids. Phar- macology & Therapeutics, 70, 475-483. doi:10.1067/mcp.2001.119213

[53]   Toh, M.L., Yang, Y., Leech, M., et al. (2004) Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen protein kinases, in rheumatoid arthritis; up-regulation by interleukin-1beta and glucocorticoids. Arthritis & Rheumatism, 50, 3118- 3128. doi:10.1002/art.20580

[54]   Harding, G., Mak, Y.T., Evans, B., et al. (2006) The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: Potential steroid-sparing role for DHEA. Cyto- kine, 36, 57-68. doi:10.1016/j.cyto.2006.10.012

[55]   Trefiletti, G., Togna, A.R, Latina, V., et al. (2011) 1-Phenyl-6,7-dihydroxy-isochroman suppresses lipopoly- saccharide-induced pro-inflammatory mediator produc- tion in human monocytes. British Journal of Nutrition, 27, 1-4.

[56]   Terzuoli, E., Donnini, S., Giachetti, A., et al. (2010) Inhi- bition of hypoxia inducible factor-1alpha by dihydroxy- phenylethanol, a product from olive oil, blocks micro- somal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis. Clinical Cancer Research, 16, 4207-4216. doi:10.1158/1078-0432.CCR-10-0156